News

05/13/2008 - Insulet Reports First Quarter 2008 Results


Read More »

05/08/2008 - Favrille Reports First Quarter 2008 Financial Results


Read More »

05/07/2008 - Achillion Reports First Quarter 2008 Financial Results


Read More »

04/24/2008 - Endogastric Solutions Announces Two Key Executive Appointments Names Vice President of Sales and Chief Financial Officer


Read More »

04/23/2008 - Argos Therapeutics Secures $35.2 Million Series C Financing


Read More »

04/16/2008 - Boston Scientific and CryoCor Announce Signing of Definitive Merger Agreement


Read More »

04/09/2008 - Favrille Announces Data Cutoff for Phase 3 Registration Trial of Specifid; Data Analysis and Unblinding Expected in June


Read More »

04/08/2008 - Achillion and FOB Synthesis Announce Collaboration for the Development of Carbapenem Compounds


Read More »

04/02/2008 - VRT Presented Before the U.S. House Committee on Veterans Affairs


Read More »

04/02/2008 - Achillion Appoints Gary E. Frashier to Board of Directors


Read More »

04/01/2008 - Karl Storz and EndoGastric Solutions Form a Strategic Alliance to Advance Natural Orifice Surgery Collaboration to Focus on Both Combined Technologies as well as Education and Training Initiatives


Read More »

03/31/2008 - Argos Therapeutics Presents Positive Phase 1 Safety Data for its Arcelis™ Platform in HIV at Keystone Symposia


Read More »

03/27/2008 - LDL Particle Measurement by NMR Recognized in Consensus Statement by the American Diabetes Association and the American College of Cardiology


Read More »

03/20/2008 - CryoCor Reports 2007 Results


Read More »

03/18/2008 - EKOS® Introduces EndoWave™ 135cm -- Longer endovascular device can treat more patients


Read More »

03/17/2008 - Insulet Reports Fourth Quarter and Full Year 2007 Results and Provides Full Year 2008 Outlook


Read More »

03/10/2008 - CryoCor Atrial Fibrillation Study Published in the Journal of the American College of Cardiology


Read More »

03/04/2008 - POINT Biomedical Corp. Announces Gilead's Madeline Miller, D.V.M., hired as VP, Clinical Operations


Read More »

02/28/2008 - Argos Therapeutics Presents Data on the Mechanism of Immunosuppression by Soluble CD83 at the Canadian Society of Transplantation Congress


Read More »

02/28/2008 - CryoCor Requests International Trade Commission Investigation Into CryoCath for Patent Infringement


Read More »

02/27/2008 - Achillion Reports 2007 Fourth Quarter and Year-End Financial Results


Read More »

02/25/2008 - EndoGastric Solutions™ Announces Results of EsophyX™ Multi-Center GERD Study


Read More »

02/19/2008 - Favrille Reports Fourth Quarter and Year End 2007 Financial Results Analysis of Primary Endpoint for Phase 3 Registration Trial No Later Than July 2008


Read More »

02/13/2008 - United States Patent Office Grants CryoCor's Request for Patent Interference


Read More »

02/06/2008 - POINT Biomedical Corp. First Tranche of $50 Million in Equity Financing


Read More »

02/04/2008 - Mitralign Successfully Completes First Human Case


Read More »

02/04/2008 - Dr. Warren Jackman Joins CryoCor Scientific Advisory Board


Read More »

01/31/2008 - New Data for Achillion's Elvucitabine Demonstrate Drug's Safety, Efficacy and Suitability for Combination Therapy in HIV-Infected Patients


Read More »

01/30/2008 - Argos Therapeutics Publishes Novel Approach to Amplifying HIV Genes for Personalized Immunotherapy Treatments for HIV


Read More »

01/16/2008 - CryoCor Files Patent Infringement Lawsuits Against CryoCath


Read More »

01/07/2008 - TransMolecular Receives Orphan Drug Designation for Non-radiolabeled TM601 for the Treatment of Malignant Glioma


Read More »

01/07/2008 - Insulet Corporation and DexCom Announce Development Agreement


Read More »

01/04/2008 - CryoCor Reports Publication in Circulation for Treatment of Atrial Fibrillation


Read More »

12/03/2007 - Mitralign® Announces Closing of Series C Financing


Read More »

11/26/2007 - Achillion Announces Appointment of New Chief Medical Officer


Read More »

11/20/2007 - Broncus Technologies Registers for IPO


Read More »

11/19/2007 - TransMolecular Reports Positive Phase 2 Data from Study of Iodine Radiolabeled TM-601 in Recurrent Glioma


Read More »

11/16/2007 - Argos Therapeutics And Therakos, Inc. Enter Exclusive Agreement For Regulatory T Cell Technology


Read More »

11/14/2007 - Insulet Reports Third Quarter 2007 Results


Read More »

11/13/2007 - CryoCor Reports Third Quarter 2007 Results and Provides Commercial and Clinical Update


Read More »

11/02/2007 - CryoCor Appoints New Vice President of Sales and Marketing


Read More »

11/01/2007 - Argos Therapeutics Presents Positive Data On Its Personalized Cancer Immunotherapy Programs At ISTBC Meeting


Read More »

10/31/2007 - TransMolecular Reports Positive Phase 1 Trial of Iodine Radiolabeled TM-601 in Glioma


Read More »

10/25/2007 - Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results


Read More »

10/24/2007 - TransMolecular, Inc. Announces Formation of Medical Advisory Board


Read More »

10/19/2007 - TransMolecular, Inc. Names Morphotek Executive Nicholas C. Nicolaides, Ph.D., Chairman of the Board


Read More »

10/15/2007 - Achillion Reports Safety and Potent Antiviral Activity in Topline Results From Elvucitabine Phase 2 Study in HIV-Infected Patients


Read More »

09/20/2007 - The first Incisionless Transoral Fundoplication for treatment of gastroesophageal reflux is performed in the U.S. at Ohio State University and Oregon Health & Science University Medical Centers.


Read More »

08/29/2007 - EndoGastric Solutions Raises $30 Million to Fund US Commercialization


Read More »

08/28/2007 - NovaVision Vision Restoration Therapy Used to Help Restore Veterans' Sight


Read More »